How to Know If Arteries Are Clogged: Symptoms & Tests

Clogged arteries often produce no symptoms at all until the blockage is severe, which is what makes the condition so dangerous. The disease process, atherosclerosis, involves a slow accumulation of fatty deposits, inflammation, and calcification inside artery walls that can take decades before anything feels wrong. When symptoms do appear, they differ depending on which arteries are affected, and the tests used to find blockages range from simple blood-pressure cuff comparisons to advanced imaging that can map coronary arteries in three dimensions. The tricky part is that the relationship between how blocked an artery looks and how much danger you face is not as straightforward as most people assume.

Why Clogged Arteries Stay Silent for So Long

Atherosclerosis begins when the inner lining of an artery becomes irritated or damaged, allowing cholesterol-carrying particles to slip beneath the surface. Over time, immune cells rush in, fat accumulates, fibrous tissue forms, and calcium deposits harden the area into what doctors call plaque. This cascade of lipid buildup, inflammation, and calcification gradually narrows the vessel.

What makes this process deceptive is a phenomenon called compensatory remodeling. Early on, the artery wall bulges outward to accommodate the growing plaque, so the channel blood flows through barely changes in size. It is only after the artery runs out of room to expand outward that the plaque starts squeezing the opening inward and restricting flow.

This means a person can have significant plaque in their artery walls for years with no reduction in blood flow and therefore no symptoms. By the time the artery narrows enough to cause problems, the disease is already well established.

Symptoms That Suggest Coronary Artery Blockages

When the arteries feeding the heart become sufficiently narrowed, the most recognizable symptom is chest pain or pressure during physical exertion, commonly called angina. It typically feels like squeezing or heaviness behind the breastbone and eases with rest. Some people describe it as shortness of breath, fatigue, or discomfort radiating to the jaw, shoulder, or left arm. Women are more likely than men to experience “atypical” symptoms like nausea, back pain, or unusual fatigue rather than classic crushing chest pressure.

The dangerous scenario is when a plaque ruptures suddenly, triggering a blood clot that blocks the artery completely. That is a heart attack, and its warning signs tend to be more intense and persistent: severe chest pain that does not let up, cold sweating, lightheadedness, and a sense that something is seriously wrong. Some heart attacks, though, produce surprisingly mild symptoms or are mistaken for indigestion, especially in women and people with diabetes whose nerve signaling can be altered.

Symptoms in the Neck and Brain

The carotid arteries run along each side of your neck and supply blood to the brain. When atherosclerosis narrows one of these arteries, symptoms tend to be neurological rather than pain-based. The classic warning event is a transient ischemic attack, sometimes called a mini-stroke: sudden weakness or numbness on one side of the body, difficulty speaking, or vision loss in one eye that resolves within minutes to hours. One case study documented a woman whose carotid stenosis presented as repeated episodes of involuntary limb shaking, initially mistaken for epilepsy before imaging revealed severe blockage from atherosclerosis.¹

Carotid artery disease can also exist alongside blockages elsewhere. In a case reviewed in JAMA, a man who experienced a brain ischemia episode was found to have severe disease not just in his carotid artery but also in his coronary and peripheral arteries.² That pattern is common. Atherosclerosis is a systemic disease, so blockages in one territory often signal disease in others.

Leg Symptoms and Peripheral Artery Disease

When the arteries in your legs become narrowed, the hallmark symptom is intermittent claudication: cramping or aching in the calves, thighs, or buttocks that starts during walking and stops when you rest. The pain comes from muscles not getting enough oxygen-rich blood during exertion, and it is predictable: the same distance or intensity of activity tends to bring it on each time.

What most people do not realize is that classic claudication is not the most common leg symptom of peripheral artery disease. A study of people with confirmed blockages found that exertional leg symptoms other than classic claudication were actually more prevalent, affecting over half of the group studied.³ These atypical symptoms include leg fatigue, difficulty walking, or pain that does not follow the neat start-with-exercise, stop-with-rest pattern. That matters because many people and even some clinicians associate peripheral artery disease only with textbook claudication, meaning atypical presentations can go unrecognized.

The mechanism behind these leg symptoms is also more complex than simple plumbing. While the arterial obstruction from plaque initiates the problem, additional factors like inflammation, dysfunction of the small blood vessels, impaired growth of new blood vessels, and changes in skeletal muscle function all contribute to how severe the symptoms feel and how well they respond to treatment.⁴

Tests That Do Not Require a Catheter

If your symptoms or risk factors raise suspicion for clogged arteries, doctors have several ways to look without threading a tube into your blood vessels. The choice of test depends on which arteries are being evaluated and what the clinical question is.

Stress testing: You exercise on a treadmill or receive a medication that simulates exercise while your heart is monitored with an electrocardiogram, echocardiogram, or nuclear imaging. The goal is to see whether parts of the heart muscle become starved for blood under increased demand. Stress tests are widely used but have limitations. They tend to detect blockages only when they are severe enough to significantly restrict flow.
CT coronary angiography: A CT scan with contrast dye produces detailed images of the coronary arteries. Advances in this technology now allow doctors to see plaque and narrowing directly, challenging the traditional role of stress testing as the default first-line imaging test for chest pain.⁵
Carotid ultrasound: A painless imaging study that uses sound waves to look at the carotid arteries in the neck. It can measure the thickness of the artery wall and detect plaque buildup. Ultrasound reliably picks up early thickening of the arterial lining and is particularly useful as an ongoing monitoring tool.⁶
Ankle-brachial index: The simplest screening test for peripheral artery disease. A clinician measures blood pressure at your ankle and your arm. If the ankle reading is substantially lower, it suggests a blockage in the leg arteries. The traditional version uses a handheld Doppler device and is considered the standard. Automated devices exist, but a comparative study found the automated method had very low sensitivity, catching only about one in five abnormal cases that the Doppler method identified.⁷ Another trial found that combining an oscillometric device with pulse wave analysis could bring sensitivity back up to a level comparable with the Doppler method.⁸

Coronary Calcium Scoring

A coronary artery calcium scan is a quick, low-dose CT scan that measures how much calcium has deposited in the walls of your heart’s arteries. It does not require contrast dye and takes only a few minutes. The result is a number called a calcium score: zero means no detectable calcium, and higher scores indicate more plaque. Because calcium deposits are a direct marker of atherosclerosis, the score gives a concrete sense of whether disease is present and roughly how extensive it is.

Calcium scoring is most useful when a person falls into a gray zone of risk, where standard factors like age, cholesterol, and blood pressure do not clearly point toward or away from aggressive treatment. A cost-effectiveness analysis found that using calcium scoring to guide statin decisions was a good value compared to treating based on risk scores alone, with an incremental cost per quality-adjusted life year of about $15,000. That said, the same analysis found calcium scanning was not cost-effective in lower-risk patients, particularly those under 50 or with less than a five percent ten-year risk of a cardiovascular event.⁹

When Catheter-Based Testing Is Needed

Invasive coronary angiography remains the gold standard for evaluating coronary blockages. A catheter is threaded from the wrist or groin into the coronary arteries, and contrast dye is injected so the arteries show up on X-ray. This gives the most direct picture of where narrowings are and how severe they look.

The catch is that a narrowing visible on the X-ray image does not always mean the blockage is actually restricting blood flow in a meaningful way. A measurement called fractional flow reserve, performed during angiography by threading a pressure-sensing wire past the blockage, can determine whether a lesion is truly limiting flow. Despite being highly informative, this test is used less often than you might expect because of added time and cost during the procedure.¹⁰ Researchers have been developing non-invasive versions of this measurement using CT angiography data, which could reduce the need for catheter-based pressure testing in some patients.

Blood Work and Risk Assessment

No blood test can directly tell you whether a specific artery is clogged. But blood work plays a major role in assessing your overall risk for atherosclerosis and in guiding treatment decisions. A standard lipid panel measuring LDL cholesterol, HDL cholesterol, and triglycerides remains the cornerstone. Current guidelines recommend checking lipids in all adults starting at age 20, with follow-up every four to six years, and considering statin therapy in younger adults whose LDL exceeds 190 or whose calculated ten-year cardiovascular risk is elevated.¹¹

High-sensitivity C-reactive protein, a marker of inflammation, is sometimes added to the panel. It can help reclassify borderline-risk patients. Other emerging biomarkers, including lipoprotein(a) and apolipoprotein B, are gaining attention as potentially better predictors of risk than standard LDL alone, though their routine use in screening is still evolving. Animal research continues to uncover new molecular players. A recent study showed that knocking out a protein called LRP3 in mice worsened atherosclerosis by disrupting both lipid metabolism and immune regulation, raising LDL, increasing plaque buildup, and promoting fibrosis.¹² Discoveries like this are still far from clinical use, but they reinforce the idea that clogged arteries result from an interplay between cholesterol levels and inflammation, not cholesterol alone.

Why a Moderate Blockage Can Be More Dangerous Than a Severe One

Here is where the science gets counterintuitive. Most people assume that a 90 percent blockage is far more dangerous than a 40 percent one. In terms of blood flow restriction, that is true. But many heart attacks occur when a plaque that is only moderately narrowing the artery suddenly ruptures, exposing its contents to the bloodstream and triggering a clot that blocks the vessel completely. These “vulnerable” plaques tend to have a thin outer shell, a large core of fatty material, and active inflammation, and they frequently are not severe enough to show up as significant blockages on a standard angiogram.¹³

A striking case report illustrated this: a 43-year-old man arrived at the hospital with classic heart attack symptoms and ST-segment changes on his electrocardiogram, but his angiogram showed only a 40 percent blockage in the left anterior descending artery. Because it looked modest, he was treated with medications rather than a stent. Follow-up imaging with optical coherence tomography later revealed that the plaque was predominantly lipid-rich with clear signs of vulnerability.¹⁴ The takeaway for you is that a clean-looking angiogram or a moderate blockage on a CT scan does not guarantee safety. Plaque composition matters at least as much as plaque size.

When Tests Look Normal but Symptoms Persist

Some people, especially women, develop classic chest pain with exertion, yet their coronary angiogram shows no significant blockages. This used to be dismissed as non-cardiac or psychological. The medical understanding has shifted dramatically. A condition sometimes called INOCA (ischemia with no obstructive coronary artery disease) is now recognized as a real and meaningful diagnosis. A subgroup of these patients has dysfunction of the tiny blood vessels that branch off the larger coronary arteries, along with evidence of inflammation.¹⁵

Two main explanations have been proposed. One centers on abnormal function of the coronary microvascular system, where the smallest vessels fail to dilate properly and restrict blood supply. The other involves altered pain perception, where the heart becomes hypersensitive to normal levels of stress.¹⁶ In many patients, both mechanisms may overlap. If you have been told your arteries are “clean” but you still have symptoms, it is worth asking about microvascular disease rather than assuming nothing is wrong.

Where Imaging Can Mislead You

Diagnostic tests for clogged arteries are powerful, but they are not infallible, and one of the most common pitfalls involves calcium. The same calcification that makes coronary artery calcium scoring useful for risk assessment can cause problems when it comes to evaluating how severe a blockage actually is on CT angiography. Heavy calcium deposits in artery walls create imaging artifacts. The calcium appears to “bloom” or spread beyond its true size on the scan, making the vessel opening look more narrowed than it really is. This can lead to false-positive diagnoses of severe blockages that are actually moderate or mild.¹⁷

This artifact, known as blooming, is a recognized limitation of CT angiography. A case report highlighted how non-invasive methods including calcium scoring, CT angiography, and even CT-derived fractional flow reserve all overestimated the severity of coronary disease in a patient with a high calcium burden.¹⁸ Researchers are actively working on software solutions, including AI-based algorithms that attempt to digitally subtract the blooming artifact, but for now, heavy calcification remains a situation where CT imaging results should be interpreted cautiously and possibly confirmed with an invasive angiogram.

The practical implication: if you have a CT angiogram that shows worrying results and you also have a high calcium score, your doctor may recommend catheter-based angiography to get a clearer picture before making treatment decisions. An overestimated blockage could lead to unnecessary procedures.

Wearable Devices and Home Monitoring

Smartwatches and fitness trackers cannot detect clogged arteries directly, but they are beginning to contribute to cardiovascular monitoring in indirect but meaningful ways. These devices collect continuous data on heart rate, activity levels, and in some cases heart rhythm, giving clinicians a much richer view of a person’s cardiovascular status than the snapshot taken during a single office visit.¹⁹

For peripheral artery disease, wearable activity monitors can track walking distance and speed over time, offering an objective measure of whether leg symptoms are worsening or improving. For heart conditions, rhythm monitoring can catch arrhythmias that sometimes coexist with coronary artery disease. None of these replace formal diagnostic testing, but they are filling a gap between scheduled medical appointments, particularly for people managing chronic cardiovascular conditions. The technology is evolving quickly, and wearable-derived data is increasingly being integrated into clinical decision-making, though it remains supplementary rather than diagnostic.

Who Should Get Screened and When

Formal screening for atherosclerosis in people without symptoms is a nuanced decision rather than a blanket recommendation. In general, adults benefit from regular lipid panels beginning at age 20, and cardiovascular risk calculators that factor in age, blood pressure, cholesterol, smoking status, and diabetes help determine whether further testing like calcium scoring or stress testing is warranted. People with a strong family history of early heart disease, those with chronic inflammatory conditions, or individuals whose risk scores fall in an intermediate zone are the strongest candidates for additional imaging.

If you have symptoms, the threshold for testing is much lower. New chest pain with exertion, unexplained shortness of breath, neurological episodes suggesting carotid disease, or leg pain that limits walking all justify prompt evaluation. The specific test your doctor orders will depend on the clinical picture: CT angiography or stress testing for suspected coronary disease, carotid ultrasound for stroke-like symptoms, and ankle-brachial index for leg complaints. Age, kidney function, and whether you can exercise also factor into the choice, since some tests require contrast dye or physical exertion.

For people with no symptoms and low risk, aggressive screening with imaging can sometimes create more anxiety and downstream testing than it prevents in actual events. A normal calcium score, for instance, is highly reassuring and can reasonably defer further workup for years. But a mildly abnormal result in a low-risk person can set off a cascade of additional scans and procedures that may not have been necessary. Screening works best when it is targeted at people whose risk profile genuinely warrants it.